AU3922601A - A radiopharmaceutical for radionuclide tumor therapy - Google Patents

A radiopharmaceutical for radionuclide tumor therapy

Info

Publication number
AU3922601A
AU3922601A AU39226/01A AU3922601A AU3922601A AU 3922601 A AU3922601 A AU 3922601A AU 39226/01 A AU39226/01 A AU 39226/01A AU 3922601 A AU3922601 A AU 3922601A AU 3922601 A AU3922601 A AU 3922601A
Authority
AU
Australia
Prior art keywords
radiopharmaceutical
tumor therapy
radionuclide tumor
radionuclide
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39226/01A
Inventor
Pedro Ortiz Armua
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Molypharma SA
Original Assignee
Molypharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molypharma SA filed Critical Molypharma SA
Publication of AU3922601A publication Critical patent/AU3922601A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU39226/01A 2000-01-28 2001-01-23 A radiopharmaceutical for radionuclide tumor therapy Abandoned AU3922601A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00200293 2000-01-28
EP00200293 2000-01-28
PCT/EP2001/000714 WO2001054734A2 (en) 2000-01-28 2001-01-23 188re-labelled 5-thio-d-glucose for radionucleotide tumor therapy

Publications (1)

Publication Number Publication Date
AU3922601A true AU3922601A (en) 2001-08-07

Family

ID=8170952

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39226/01A Abandoned AU3922601A (en) 2000-01-28 2001-01-23 A radiopharmaceutical for radionuclide tumor therapy

Country Status (2)

Country Link
AU (1) AU3922601A (en)
WO (1) WO2001054734A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100430061B1 (en) * 2000-03-21 2004-05-03 재단법인 아산사회복지재단 Radioisotope labeled complex of glucose derivatives and kit for preparation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE239745T1 (en) * 1996-12-18 2003-05-15 Nihon Mediphysics Co Ltd NITRIDE HETEROCOMPLEXES OF RADIOACTIVE TRANSITION METALS
WO1999020316A1 (en) * 1997-10-20 1999-04-29 Board Of Regents, The University Of Texas System Single photon-emitting radiotraces and methods for their use

Also Published As

Publication number Publication date
WO2001054734A3 (en) 2001-12-06
WO2001054734A2 (en) 2001-08-02

Similar Documents

Publication Publication Date Title
AU2001237827A1 (en) Radioactive therapeutic liposomes
GB0023983D0 (en) Therapeutic compounds
GB2367472B (en) Radiation therapy planning
GB0008710D0 (en) Therapeutic compounds
GB0016681D0 (en) Therapeutic compounds
GB0028429D0 (en) Therapy
AU5558499A (en) Radioactive therapeutic seeds
GB9930570D0 (en) Therapy
GB0028583D0 (en) Therapeutic compounds
GB9907243D0 (en) Therapy
GB9900222D0 (en) Therapeutic compounds
AUPR320701A0 (en) The new cancer therapeutic agent with a thiopeptides
EP1242064A4 (en) Liver selective therapy
AU3922601A (en) A radiopharmaceutical for radionuclide tumor therapy
AU2001268744A1 (en) Characterizing a brain tumor
HK1041455A1 (en) A cancer thermotherapy
AU3567500A (en) Photodynamic therapy compounds
GB0013105D0 (en) Therapeutic compounds
AUPR036500A0 (en) Tumour radiotherapy
AUPR773101A0 (en) Multiple targeted radionuclide therapy for cancer
GB0015215D0 (en) Tumour therapy
GB9908804D0 (en) Radiotherapy
GB9913084D0 (en) Tumour therapy
SI1296722T1 (en) Radiotherapy
AU2002259248A1 (en) Radioactive therapeutic seeds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase